Cell Therapy Enabling Technologies
Accelerating the development of cell based immunotherapies and regenerative medicines.
// Technology
Platforms
An Integrated Ecosystem to Spur Discovery
We have developed multiple platforms aimed at overcoming the immunosuppressive tumor microenvironment and enhancing immune cell function and proliferation in cell therapies, capable of enabling engineering T cells, NK cells, and induced pluripotent stem cell (iPSCs).
Setting a New Standard in iPSCs
Our Integrated Technology Platforms Fueling the Discoveries of Tomorrow
Gene
Editing
We have a powerful suite of proprietary gene editing technologies to accelerate the development of life-changing and curative therapies for patients.
RNA, Protein, and Vector Engineering
We have centralized RNA, protein, and vector engineering to improve productivity and scalability and to ensure external partners and internal programs have access to the necessary tools to build novel therapies.
Our Therapeutic Approaches
We are enabling the development of a range of ex vivo and in vivo cell and gene therapies, leveraging our in-house capabilities and expertise to design and develop an array of modalities.
End-to-End Capabilities
We help our partners scale new heights in cell and gene therapies by providing a full spectrum of viral vector and cell therapy capabilities to bring concepts to commercialization.
Partner with ElevateBio®
Wherever you are in your product lifecycle, we can strengthen and accelerate the development of your transformative therapies with our enabling technologies unmatched manufacturing capabilities.
// Work with us
